• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性1型多发性内分泌肿瘤相关胰腺肿瘤中的多个等位基因缺失及肿瘤内基因异质性

Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.

作者信息

Hessman O, Skogseid B, Westin G, Akerström G

机构信息

Department of Surgical Sciences, Endocrine Unit, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.

出版信息

J Clin Endocrinol Metab. 2001 Mar;86(3):1355-61. doi: 10.1210/jcem.86.3.7332.

DOI:10.1210/jcem.86.3.7332
PMID:11238532
Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome with multiple tumors of the endocrine pancreas, the parathyroid, the pituitary, and other tissues. The MEN1 gene at 11q13 is homozygously mutated in the majority of MEN1 tumors. Here we present a genome-wide loss of heterozygosity (LOH) screening of 23 pancreatic lesions, one duodenal tumor, and one thymic carcinoid from 13 MEN1 patients. Multiple allelic deletions were found. Fractional allelic loss varied from 6-75%, mean 31%. All pancreatic tumors displayed LOH on chromosome 11, whereas the frequency of losses for chromosomes 3, 6, 8, 10, 18, and 21 was over 30%. Different lesions from individual patients had discrepant patterns of LOH. Intratumoral heterogeneity was revealed, with chromosome 6 and 11 deletions in most tumor cells, whereas other chromosomal loci were deleted in portions of the analyzed tumor. Chromosome 6 deletions were mainly found in lesions from patients with malignant features. Fractional allelic loss did not correlate to malignancy or to tumor size. Our findings indicate that MEN1 pancreatic tumors fail to maintain DNA integrity and demonstrate signs of chromosomal instability.

摘要

多发性内分泌腺瘤1型(MEN1)是一种遗传性综合征,在内分泌胰腺、甲状旁腺、垂体及其他组织中会出现多个肿瘤。11q13处的MEN1基因在大多数MEN1肿瘤中发生纯合突变。在此,我们对13例MEN1患者的23个胰腺病变、1个十二指肠肿瘤和1个胸腺类癌进行了全基因组杂合性缺失(LOH)筛查。发现了多个等位基因缺失。等位基因缺失率在6%至75%之间,平均为31%。所有胰腺肿瘤在11号染色体上均显示杂合性缺失,而3号、6号、8号、10号、18号和21号染色体的缺失频率超过30%。个体患者的不同病变具有不同的杂合性缺失模式。揭示了肿瘤内的异质性,大多数肿瘤细胞中6号和11号染色体缺失,而在部分分析的肿瘤中其他染色体位点缺失。6号染色体缺失主要见于具有恶性特征患者的病变中。等位基因缺失率与恶性程度或肿瘤大小无关。我们的研究结果表明,MEN1胰腺肿瘤无法维持DNA完整性,并表现出染色体不稳定的迹象。

相似文献

1
Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.男性1型多发性内分泌肿瘤相关胰腺肿瘤中的多个等位基因缺失及肿瘤内基因异质性
J Clin Endocrinol Metab. 2001 Mar;86(3):1355-61. doi: 10.1210/jcem.86.3.7332.
2
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.11号染色体长臂13区等位基因缺失在1型多发性内分泌腺瘤相关和散发性胃泌素瘤及胰腺内分泌肿瘤中的情况。
Cancer Res. 1997 Jun 1;57(11):2238-43.
3
Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.来自个别多发性内分泌腺瘤1型(MEN1)患者的多种肿瘤中11q13染色体上的等位基因缺失。
Cancer Res. 1996 Nov 15;56(22):5272-8.
4
Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.非家族性及与多发性内分泌腺瘤1型相关的胰腺内分泌肿瘤中3p、11q13和18q的基因改变
Genes Chromosomes Cancer. 1999 Nov;26(3):258-64.
5
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.基于杂合性缺失分析的I型多发性内分泌肿瘤(MEN1)基因定位
Cancer Res. 1997 May 15;57(10):1855-8.
6
Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.与1型多发性内分泌肿瘤综合征无关的胃神经内分泌肿瘤中11q13 - 14区域杂合性缺失
Lab Invest. 1999 Jun;79(6):671-7.
7
Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Int J Oncol. 2002 May;20(5):971-6.
8
Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.散发性胰腺内分泌肿瘤中MENIN基因的突变
Cancer Res. 1998 Oct 1;58(19):4417-20.
9
Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.多发性内分泌腺瘤病1型(MEN1):对一个患病家族和散发病例的杂合性缺失研究。
Anticancer Res. 1998 Jul-Aug;18(4A):2685-9.
10
Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome.1型多发性内分泌肿瘤综合征患者不同病理组织中11号染色体可变区缺失
J Clin Endocrinol Metab. 1994 Nov;79(5):1498-502. doi: 10.1210/jcem.79.5.7962349.

引用本文的文献

1
Menin: from molecular insights to clinical impact.Menin:从分子洞察到临床影响
Epigenomics. 2025 May;17(7):489-505. doi: 10.1080/17501911.2025.2485019. Epub 2025 Mar 28.
2
Menin in Cancer.Menin 在癌症中的作用。
Genes (Basel). 2024 Sep 21;15(9):1231. doi: 10.3390/genes15091231.
3
Malignant insulinoma: Can we predict the long-term outcomes?恶性胰岛素瘤:我们能否预测其长期预后?
World J Clin Cases. 2022 Jun 6;10(16):5124-5132. doi: 10.12998/wjcc.v10.i16.5124.
4
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.胰腺神经内分泌肿瘤:分子机制与治疗靶点
Cancers (Basel). 2021 Oct 12;13(20):5117. doi: 10.3390/cancers13205117.
5
ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).散发性神经内分泌肿瘤和多发性内分泌腺瘤病 1 型(MEN1)患者的 ARMC5 改变。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4531-42. doi: 10.1210/clinem/dgaa631.
6
Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.基因表达谱分析显示,MCM3 作为标志物在预测浸润性导管乳腺癌患者预后方面优于 Ki67。
Clin Exp Med. 2020 May;20(2):249-259. doi: 10.1007/s10238-019-00604-4. Epub 2020 Jan 24.
7
Surgical and molecular pathology of pancreatic neoplasms.胰腺肿瘤的外科与分子病理学
Diagn Pathol. 2016 Jun 7;11(1):47. doi: 10.1186/s13000-016-0497-z.
8
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.小肠神经内分泌肿瘤的肝转移:Ki-67异质性及与原发肿瘤的世界卫生组织分级不一致
Am J Clin Pathol. 2015 Mar;143(3):398-404. doi: 10.1309/AJCPQ55SKOCYFZHN.
9
Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.1型多发性内分泌腺瘤病家族中由胸腺类癌引起的家族性库欣综合征。
Endocrine. 2014 Sep;47(1):183-90. doi: 10.1007/s12020-013-0141-6. Epub 2014 Jan 23.
10
MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.MEN1 是一种黑色素瘤肿瘤抑制因子,通过刺激同源重组指导的 DNA 修复相关基因的转录来维持基因组的完整性。
Mol Cell Biol. 2013 Jul;33(13):2635-47. doi: 10.1128/MCB.00167-13. Epub 2013 May 6.